After receiving over $300,000 from the N.C. Biotechnology Center, Winston-Salem regenerative medicine startup Plakous Therapeutics is now looking to raise $10 million in equity. CEO Robert Boyce said that this funding will help advance Plakous' medicine through various testing and studies with the goal of beginning a human trial.
